- Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. Lang, P., Barbin, K., Feuchtinger, T., Greil, J., Peipp, M., Zunino, S.J., Pfeiffer, M., Handgretinger, R., Niethammer, D., Fey, G.H. Blood (2004)